Literature DB >> 19892042

The role of complement in innate and adaptive immunity to pneumococcal colonization and sepsis in a murine model.

D Bogaert1, C M Thompson, K Trzcinski, R Malley, M Lipsitch.   

Abstract

Streptococcus pneumoniae is an important bacterial cause of sepsis, meningitis, pneumonia and otitis media. Pneumococcal disease is generally preceded by mucosal colonization with the homologous strain; hence, resistance to colonization may be an important aspect of resistance to disease. In humans, complement deficiency is a risk factor for the development of pneumococcal disease. Although many studies have shown protective effects of complement during pneumonia and meningitis, there have been no studies reported that evaluate the role of complement in containment of pneumococcal colonization. To this end, we studied the role of complement in preventing the progression of pneumococcal mucosal colonization to sepsis in a mouse model. Sepsis developed in 60% of complement-depleted mice following intranasal pneumococcal challenge, but not in control or neutrophil-depleted mice. Colonization density in the nasopharynx and local mucosal tissue was similar between complement-depleted and control mice before onset of sepsis. Immunization of complement-depleted mice with an intranasally administered whole cell pneumococcal vaccine (WCV) reduced progression towards sepsis and protected surviving mice against colonization comparably to complement-sufficient mice. We therefore conclude that complement prevents sepsis following pneumococcal colonization in a neutrophil-independent fashion, but and WCV-induced adaptive immunity is complement-independent.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19892042      PMCID: PMC2810519          DOI: 10.1016/j.vaccine.2009.10.085

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  15 in total

1.  Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococci.

Authors:  R Malley; M Lipsitch; A Stack; R Saladino; G Fleisher; S Pelton; C Thompson; D Briles; P Anderson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

2.  CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization.

Authors:  Richard Malley; Krzysztof Trzcinski; Amit Srivastava; Claudette M Thompson; Porter W Anderson; Marc Lipsitch
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

3.  Protective role of complement in the development of experimental pneumococcal pneumonia in mice.

Authors:  R Nakajima; K Namba; Y Ishida; T Une; Y Osada
Journal:  Chemotherapy       Date:  1990       Impact factor: 2.544

4.  Innate immune defense against pneumococcal pneumonia requires pulmonary complement component C3.

Authors:  Alison R Kerr; Gavin K Paterson; Alan Riboldi-Tunnicliffe; Tim J Mitchell
Journal:  Infect Immun       Date:  2005-07       Impact factor: 3.441

5.  Complement C1q and C3 are critical for the innate immune response to Streptococcus pneumoniae in the central nervous system.

Authors:  Tobias A Rupprecht; Barbara Angele; Matthias Klein; Juergen Heesemann; Hans-Walter Pfister; Marina Botto; Uwe Koedel
Journal:  J Immunol       Date:  2007-02-01       Impact factor: 5.422

Review 6.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

7.  C1 inhibitor treatment improves host defense in pneumococcal meningitis in rats and mice.

Authors:  Petra J G Zwijnenburg; Tom van der Poll; Sandrine Florquin; Machteld M J Polfliet; Timo K van den Berg; Christine D Dijkstra; John J Roord; C Erik Hack; A Marceline van Furth
Journal:  J Infect Dis       Date:  2007-05-17       Impact factor: 5.226

8.  Antibody-independent, interleukin-17A-mediated, cross-serotype immunity to pneumococci in mice immunized intranasally with the cell wall polysaccharide.

Authors:  Richard Malley; Amit Srivastava; Marc Lipsitch; Claudette M Thompson; Claire Watkins; Arthur Tzianabos; Porter W Anderson
Journal:  Infect Immun       Date:  2006-04       Impact factor: 3.441

9.  Epidemiologic studies of Streptococcus pneumoniae in infants. The effects of season and age on pneumococcal acquisition and carriage in the first 24 months of life.

Authors:  B M Gray; M E Turner; H C Dillon
Journal:  Am J Epidemiol       Date:  1982-10       Impact factor: 4.897

10.  Cirrhosis-induced defects in innate pulmonary defenses against Streptococcus pneumoniae.

Authors:  Katie L Propst-Graham; Laurel C Preheim; Elizabeth A Vander Top; Mary U Snitily; Martha J Gentry-Nielsen
Journal:  BMC Microbiol       Date:  2007-10-23       Impact factor: 3.605

View more
  16 in total

1.  Role of capsule and suilysin in mucosal infection of complement-deficient mice with Streptococcus suis.

Authors:  Maren Seitz; Andreas Beineke; Alena Singpiel; Jörg Willenborg; Pavel Dutow; Ralph Goethe; Peter Valentin-Weigand; Andreas Klos; Christoph G Baums
Journal:  Infect Immun       Date:  2014-03-31       Impact factor: 3.441

Review 2.  Serotype replacement in disease after pneumococcal vaccination.

Authors:  Daniel M Weinberger; Richard Malley; Marc Lipsitch
Journal:  Lancet       Date:  2011-04-12       Impact factor: 79.321

Review 3.  Pathogenesis and pathophysiology of pneumococcal meningitis.

Authors:  Barry B Mook-Kanamori; Madelijn Geldhoff; Tom van der Poll; Diederik van de Beek
Journal:  Clin Microbiol Rev       Date:  2011-07       Impact factor: 26.132

4.  Increased chain length promotes pneumococcal adherence and colonization.

Authors:  Jesse L Rodriguez; Ankur B Dalia; Jeffrey N Weiser
Journal:  Infect Immun       Date:  2012-07-23       Impact factor: 3.441

5.  Modulation of brain injury as a target of adjunctive therapy in bacterial meningitis.

Authors:  Uwe Koedel; Matthias Klein; Hans-Walter Pfister
Journal:  Curr Infect Dis Rep       Date:  2010-07       Impact factor: 3.725

Review 6.  What have we learned from murine models of otitis media?

Authors:  Hayley E Tyrer; Michael Crompton; Mahmood F Bhutta
Journal:  Curr Allergy Asthma Rep       Date:  2013-10       Impact factor: 4.806

7.  Streptococcus pneumoniae capsular serotype invasiveness correlates with the degree of factor H binding and opsonization with C3b/iC3b.

Authors:  Catherine Hyams; Krzysztof Trzcinski; Emilie Camberlein; Daniel M Weinberger; Suneeta Chimalapati; Mahdad Noursadeghi; Marc Lipsitch; Jeremy S Brown
Journal:  Infect Immun       Date:  2012-11-12       Impact factor: 3.441

8.  A novel mutation in the complement component 3 gene in a patient with selective IgA deficiency.

Authors:  Elisangela Santos-Valente; Ismail Reisli; Hasibe Artaç; Raphael Ott; Özden Sanal; Kaan Boztug
Journal:  J Clin Immunol       Date:  2012-09-21       Impact factor: 8.317

Review 9.  Panel 4: Recent advances in otitis media in molecular biology, biochemistry, genetics, and animal models.

Authors:  Jian-Dong Li; Ann Hermansson; Allen F Ryan; Lauren O Bakaletz; Steve D Brown; Michael T Cheeseman; Steven K Juhn; Timothy T K Jung; David J Lim; Jae Hyang Lim; Jizhen Lin; Sung-Kyun Moon; J Christopher Post
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04       Impact factor: 3.497

10.  Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.

Authors:  Daniel R Feikin; Eunice W Kagucia; Jennifer D Loo; Ruth Link-Gelles; Milo A Puhan; Thomas Cherian; Orin S Levine; Cynthia G Whitney; Katherine L O'Brien; Matthew R Moore
Journal:  PLoS Med       Date:  2013-09-24       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.